معرفی
Jonathan Ellman is the Eugene Higgins Professor of Chemistry and Professor of Pharmacology at Yale University, with joint appointments in the Department of Chemistry and the Department of Pharmacology at the Yale School of Medicine. He is also affiliated with the Yale Cancer Center and the Developmental Therapeutics program.
Education:
- PhD, Chemistry, Harvard University (1989)
- BS, Chemistry, MIT (1984)
- NSF Postdoctoral Fellow, University of California at Berkeley (1992)
Dr. Ellman's research lies at the intersection of synthetic organic chemistry and biomedical science, focusing on the development of novel synthetic methodologies and their application to drug discovery. His work emphasizes catalysis, particularly in C–H activation and enantioselective synthesis, with a strong interest in sulfur-containing compounds such as sulfoximines and sulfilimines as bioactive motifs. His lab has pioneered methods for constructing complex amine and amide architectures with quaternary centers, which are valuable in medicinal chemistry. A recent focus includes targeting opioid receptors for pain therapeutics with reduced side effects. His research has led to over 350 publications and significant contributions to chemical biology and pharmaceutical sciences.
His recent publications reveal a consistent focus on catalytic methodologies, sulfur chemistry, and computational drug design, particularly in targeting opioid receptors. Themes include enantioselective synthesis, C–H functionalization, and the exploration of underutilized heteroatom-containing functional groups in drug discovery.
Scientific Awards and Honors:
- Member, American Academy of Arts and Sciences (2016)
- Yale Dylan Hixon ’88 Prize for Teaching Excellence in the Natural Sciences (2016)
- Herbert C. Brown Award for Creative Research in Synthetic Methods (2012)
- GlaxoSmithKline Chemistry Scholar Award (2010)
- Pedler Award, Royal Society of Chemistry (2010)
Dr. Ellman has trained numerous researchers and maintains a highly collaborative research program, evidenced by frequent co-authorship with colleagues across Yale. His lab, accessible via ellman.chem.yale.edu, is part of Yale’s broader research ecosystem in chemical biology and therapeutics. He has received continuous grant support, particularly in the areas of synthetic methods development and translational chemical biology, although specific grants are not detailed in the text.
